UVUmut Varol

Umut Varol

*This is an algorithmically generated author record based on publicly available information.

Umut Varol has a total of 133 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Early detection of tamoxifen-induced retinal injury: ellipsoid zone reflectivity as a sensitive structural marker

    by Barbaros Hayrettin Unlu, Seher Koksaldı, Ceren Durmaz Engin, Umut Varol

    To investigate early structural alterations in the outer retina and choroid of tamoxifen-treated patients without clinically detectable retinopathy by quantitatively assessing reflectivity changes of the external limiting membrane (ELM), ellipsoid zone (EZ), and retinal pigment epithelium (RPE), along with the choroidal vascularity index (CVI). The study included 45 eyes of 45 tamoxifen-treated women and 50 eyes of 50 age- and sex-matched healthy female controls. ELM, EZ, and RPE reflectivity was measured along foveal, parafoveal, and perifoveal axes. CVI was derived using a standardized binarization method. Correlations between reflectivity metrics and tamoxifen exposure indices were analyzed. Tamoxifen users showed a marked reduction in EZ reflectivity at the central fovea and at the temporal perifovea (p = 0.005 and p = 0.037, respectively), accompanied by a corresponding decrease in relative EZ values at the central fovea and at the temporal parafovea (p = 0.012 and p = 0.039, respectively). In contrast, ELM and RPE reflectivity metrics remained stable across all evaluated regions (p > 0.05). CVI measurements revealed no significant differences between the patient and control groups (p > 0.05). Within the tamoxifen cohort, treatment duration demonstrated weak but significant positive associations with central foveal ELM reflectivity (r = 0.389, p = 0.008), whereas age was negatively correlated with EZ reflectivity in the nasal parafoveal region (r = - 0.331, p = 0.026). Early tamoxifen exposure appears to affect the EZ before detectable alterations become evident in the ELM, RPE, or choroid. These findings suggest that subtle EZ disruption may represent an early structural indicator of tamoxifen-related retinal involvement and could potentially aid in identifying patients who may require closer monitoring. However, longitudinal studies are needed to confirm these findings and clarify their clinical significance.

  • Relevancy of Serum SuPAR, PAI-1, MMP-9 Level, and Prognosis of Metastatic Colorectal Cancer During Diagnosis

    by Mehmet Eren Kalender, Leyla Demir, Utku Oflazoglu, Yuksel Kucukzeybek, Tarik Salman, Umut Varol, Yasar Yildiz, Zeynep Sevgen Güç, Halil Taskaynatan, Ahmet Alacacıoglu

    Objectives: Serum suPAR, PAI-1, and MMP-9 biomarkers have been associated with the progression of the disease in many cancers, including the CRC. It aimed to determine the relation of serum suPAR, PAI-1, and MMP-9 levels with the prognosis of the disease in patients with mCRC. Methods: Nonmetastatic CRC patients who had not yet been treated with the oncology polyclinic in İKCU and blood samples were taken from the patients with metastatic CRC before and after treatment, and the obtained serum was preserved. PAI-1, suPAR, and MMP-9 levels were studied by ELISA. The results were used to establish the relation with prognosis. Results: When the metastatic CRC and non-metastatic CRC were compared before treatment for biomarkers; PAI-1(p-value: 0.030), suPAR(p-value: 0.009) and MMP-9(p-value: 0.003) were found to be highly significant. PAI-1 (p-value: 0.003), suPAR (p-value: 0.007), and MMP-9 (p-value: 0.001) in the pretreatment metastatic group and the control group after the treatment were statistically significant. ROC was performed and cut-off values were determined as (pai: 71.4 ng/ ml; supar: 1.97 ng/ ml; mmp: 812.5 ng/ ml). PFS and OS were evaluated to the cut-offs of markers using the Kaplan-Meier method. Cut off values were significant in terms of PFS (pai p-value, 0.008; supar p-value 0.019, mmp p-value 0.017) and OS (pai p-value, 0.03; supar p-value 0.059, mmp p-value 0.081). Conclusion: Serum PAI-1, suPAR, and MMP-9 levels reveal the prognosis of patients with metastatic CRC.

  • Factors affecting burnout in physicians during COVID-19 pandemic

    by Osman Hasan Tahsin Kiliç, Murat Anil, Umut Varol, Zeynep Sofuoğlu, İsTemihan Çoban, Hakan Gülmez, Güven Güvendi̇, Berna Di̇rİm Mete

    Aim: The COVID-19 outbreak continues to pose a threat to people's physical and mental health all over the world. The health professionals who are directly involved in the fight against the pandemic may experience stress during this crisis that can cause Burnout and Secondary traumatic stress. The objective of our study was to assess the burnout among physicians during COVID-19 pandemic and to determine related factors. Materials and Methods: A cross-sectional online survey was conducted. The demographical and occupational data were collected using a questionnaire and burnout level was assessed by Maslach Burnout Inventory (MBI). Results: 748 physicians took the survey. The burnout levels stated by the physicians were found to be significantly higher than before the pandemic [median before pandemic 3 (CDA: 2-4); median 4 (2-5) during pandemic; p <0.001]. Personal Accomplishment (PA), Emotional Exhaustion (EE) and Depersonalization (D) scores of participants directly providing medical services to COVID-19 cases were significantly higher (p <0.05). While EE and D scores were highest in first step workers, PA scores were highest in third step workers. PA scores were lower in man and EE scores were higher in women (p<0.05). Negative correlation was found between the age and the EE [r: (-) 0.087; p< 0.017] and D [r: (-) 0.233; p<0.001] subscale scores. Conclusion: We concluded that women, younger, first step and frontline workers had higher risks for burnout, so individual, structural, and organizational arrangements should be made by giving priority to these risky groups.


  • Open Access

    Neuroendocrine Differentiated Breast Cancer Cases: A Retrospective Analysis and Literature Review

    by Ozlem Ozdemir, Baha Zengel, Yasar Yildiz, Seray Saray, Ahmet Alacacioglu, Funda Tasli, Zuleyha Can Erdi, Utku Oflazoglu, Halil Taskaynatan, Tarik Salman, et al.

    The Medical Bulletin of Sisli Etfal Hospital


  • Opere Over Kanseri Hastalarında Preoperatif Yüksek CA125 Değerinin Postoperatif Normal Sınırlara Dönmesinin Klinik Önemi

    by Umut Varol, Nagihan Akkaş, Utku Oflazoğlu, Tarık SALMAN, Halil Taskaynatan, Seray Saray, Yaşar YILDIZ, Ahmet Alacacioğlu, Yüksel Küçükzeybek, Mustafa Tarhan

    Amaç: CA125, over kanseri hastalarında gerek tanı aşamasında gerekse tedavi sonrası takiplerde tümör belirteci olarak kullanılmaktadır. Biz de çalışmamızda preoperatif serum CA125 değeri yüksek olan over kanseri hastalarında operasyondan sonraki değerlerinin normale dönüp dönmemesinin nüks riskini belirleme ve nükse kadar geçen süre açısından önemini araştırdık. Yöntem: Çalışmamızda 2005 – 2013 yılları arasında İzmir Katip Çelebi Üniversitesi Atatürk Eğitim ve Araştırma Hastanesi Tıbbi Onkoloji Kliniğinde opere over kanseri tanısıyla takip ve tedavi edilen hastalar retrospektif olarak taranmıştır. CA125 sınır değeri olarak hem 35 IU/ml hem de 65 IU/ml kullanılarak iki farklı analiz yapılmıştır. Bulgular: Çalışmamıza bazal CA125 değeri yüksek olan (sınır değer >35 IU/ml ve 65 IU/ml alındığında) sırasıyla 132 ve 119 hasta alınmıştır. Preoperatif CA125 değeri yüksek olup postoperatif normale gelen hastaların sayısı sırasıyla 54 ve 58 iken bu değeri normalleşmeyen hastaların sayısı 78 ve 61’dir. Her iki CA125 sınır değeri için, postoperatif CA125 değeri normalleşenlerle normalleşmeyen hastalarda hem nükse kadar geçen süre (32 aya karşı 18 ay p:0,015 - 32 aya karşı 17 ay p:0,001) hem de tüm sağkalım açısından (108 aya karşı 36 ay p:0,015 - 89 aya karşı 33 ay p:0,000) istatistiksel anlamlı fark saptanmıştır. Sonuç: Opere over kanseri hastalarından bazal CA125 değeri yüksek saptanan hastalarda ameliyat sonrasındaki düşüşü değerlendirip, bu değerin normal sınırlara düşüp düşmemesine göre nüks süreci hakkında fikir sahibi olunabilinir.

  • Open Access

    A prospective randomized controlled trial of metoclopramide combined with triple antiemetic therapy to prevent anthracycline-based chemotherapy-induced nausea and vomiting in patients with breast cancer

    by U. Oflazoglu, U. Varol, A. Alacacioglu, T. Salman, Y. Kucukzeybek, H. Taskaynatan, Y. Yildiz, G. Dissiz, S. Iriz, M.O. Tarhan

    Background: Triple antiemetic therapy, such as a 5-HT3 receptor antagonist (5H3-RA), aprepitant and dexamethasone, is recommended for the prophylaxis of highly emetogenic chemotherapy induced nausea and vomiting in patients with breast cancer. In the present study, we aimed to verify whether adding metoclopramide to the triplet antiemetic therapy is superior to the triplet antiemetic therapy in preventing CINV in patients with breast cancer.


  • Prognostic Value of Neutrophil/Lymphocyte Ratio (NLR), Platelet/Lymphocyte Ratio (PLR) and Mean Platelet Volume (MPV) In Patients with Colorectal Carcinoma [Izmir Oncology Group(IZOG) Study]

    by Utku Oflazoglu, Ahmet Alacacioglu, Isıl Somali, Melike Yuce, Abdullah Murat Buyruk, Umut Varol, Tarik Salman, Halil Taskaynatan, Yasar Yildiz, Yuksel Kucukzeybek, et al.


  • Thrombin activatable fibrinolysis inhibitor, tissue factor pathway inhibitor, and prothrombin fragment 1+2 levels in patients with advanced colorectal cancer.

    by Tarik Salman, Ahmet Bilici, Cagatay Arslan, Umut Varol, Ibrahim Yildiz, Murat Akyol, Yasar Yildiz, Yuksel Kucukzeybek, Ahmet Alacacioglu, Ugur Yilmaz

    615 Background: Thromboembolism is common in cancer patients.Thrombin activatable fibrinolysis inhibitor (TAFI), tissue factor pathway inhibitor (TFPI) and prothrombin fragment 1+2 (F1+2) are newly identified molecules involved in coagulation and fibrinolysis. The aim of this study was to investigate the relationship between clinicopathologic characteristics and TAFI, TFPI and F1+2 levels in patients with advanced colorectal cancer. Methods: Eighty-two patients (32 metastatic, 50 locally advanced disease) diagnosed with colorectal cancer in the medical oncology clinic, without history of thromboembolism, had not undergone an intervention, and not on medication affecting coagulation were included in the study. Serum TAFI, TFPI, and prothrombin F1+2 levels were evaluated via enzyme-linked immunosorbent assay. Clinicopathologic characteristics of the patients were investigated retrospectively from the medical records of the patients. Results: The plasma TAFI, TFPI, and prothrombin F1+2 levels were high in 70, 71, and 96% of the patients, respectively. Prothrombin F1+2 levels were higher among patients with lower performance scores. TFPI levels were higher among patients with tumor grades of 2 and 3. TAFI levels were higher among rectal cancer cases. Conclusions: There is an association between tumor grade and coagulation cascade. The higher prothrombin F1+2 levels, an indicator of active coagulation cascade, among patients with low performance scores may indicate that the coagulation cascade of these patients is more active. Higher TAFI levels among rectal cancer patients may be related to the natural course of the disease


  • Evaluation of c-kit (CD 117) expression as a prognostic factor in testicular germ cell tumors: An Izmir Oncology Group (IZOG) study.

    by Tarik Salman, Elif Yildiz, Ibrahim Yildiz, Dilek Yavuzer, Mehtat Unlu, Umut Varol, Murat Akyol, Yasar Yildiz, Vedat Bayoglu, Yuksel Kucukzeybek, et al.

    476 Background: Little progress has been made in the management of testicular germ cell tumors (TGCTs). c-kit (CD 117) is a good target for cancer treatment and possesses an impressive role in the current oncological practice. We aimed to evaluate c-kit expression in early stage TGCTs as a prognostic factor. Methods: Patients with TGCTs who were referred to the Medical Oncology Clinic were included in our study before starting chemotherapy. Immunohistochemistry was performed on formalin-fixed and paraffinembedded three-micrometer thick sections with CD 117 Rabbit Anti c-kit in vitro gene kit. Biochemically, we utilized AFP and β-HCG Immunlite 2000 device with solid phase chemiluminescent immunometric method, and LDH Roche models with the DP-standardized UV method. AFP 0-15 ng/ml, β-HCG < 0.1 mlu/ml and LDH 240-480 mg/dl were considered as normal values. Results: Sixty-five patients were included in our study. Forty-one (63%) patients had nonseminoma tumors (NSGCTs) and 24 (37%) had seminoma. Statistically significant c-kit expression was found in patients with seminoma (p